Literature DB >> 6933506

beta-Endorphin: stability, clearance behavior, and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits.

R A Houghten, R W Swann, C H Li.   

Abstract

Rabbits and rats were given intravenous injections of tritiated human beta-endorphin. The levels of beta-endorphin were followed by the decrease in radioactivity in the plasma of rats or rabbits and by the increase in radioactivity in the cerebrospinal fluid of the rabbit. The results were identical with the tritium label on either tyrosine-1 or -27. The plasma distribution times were 2 and 5 min in the rat and rabbit, respectively, with a later clearance time of approximately 1-8 hr. In the rat, approximately 50% of the radioactivity in the plasma was found to be intact human beta-endorphin 45 min after injection. Radioactivity appeared in the cerebrospinal fluid of the rabbit within 30 sec after injection and reached a plateau in approximately 60-90 min after injection. Approximately 75% of the radioactivity in the cerebrospinal fluid of the rabbit was intact human beta-endorphin. In the brain hemispheres of the rat and the rabbit, the only significant radiolabeled product was found to be radioactive tyrosine. Moreover, rat plasma levels of beta-endorphin decreased dramatically after hypophysectomy, which only slightly lowered the levels in the brain. It appears that beta-endorphin, upon entry into the plasma, is either not significantly taken up into the brain or is broken down with extreme rapidity upon entry into the brain, although it apparently does enter the cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933506      PMCID: PMC349889          DOI: 10.1073/pnas.77.8.4588

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  beta-Endorphin: a pituitary peptide with potent morphine-like activity.

Authors:  C H Li
Journal:  Arch Biochem Biophys       Date:  1977-10       Impact factor: 4.013

2.  Beta-Endorphin as a potent analgesic by intravenous injection.

Authors:  L F Tseng; H H Loh; C H Li
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

3.  Beta-endorphin--induced changes in schizophrenic and depressed patients.

Authors:  N S Kline; C H Li; H E Lehmann; A Lajtha; E Laski; T Cooper
Journal:  Arch Gen Psychiatry       Date:  1977-09

4.  Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies.

Authors:  F Bloom; E Battenberg; J Rossier; N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

5.  Synthesis and analgesic activity of human beta-endorphin.

Authors:  C H Li; D Yamashiro; L F Tseng; H H Loh
Journal:  J Med Chem       Date:  1977-03       Impact factor: 7.446

6.  Human beta-endorphin: development of tolerance and behavioral activity in rats.

Authors:  L F Tseng; H H Loh; C H Li
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

7.  Pharmacologic activity of beta-endorphin in man.

Authors:  D H Catlin; K K Hui; H H Loh; C H Li
Journal:  Commun Psychopharmacol       Date:  1977

8.  The analgesic activity of human beta-endorphin in man (1,2,3).

Authors:  Y Hosobuchi; C H Li
Journal:  Commun Psychopharmacol       Date:  1978

9.  The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum.

Authors:  H W Kosterlitz; R J Lydon; A J Watt
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

10.  Rat of disappearance of human beta-lipotropin and beta-endorphin in adult male rats as estimated by radioimmunassay.

Authors:  W C Chang; A J Rao; C H Li
Journal:  Int J Pept Protein Res       Date:  1978-01
View more
  16 in total

Review 1.  Peripheral modulation of learning and memory: enkephalins as a model system.

Authors:  G Schulteis; J L Martinez
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Opioid peptides and metabolic regulation.

Authors:  D Giugliano; R Torella; P J Lefèbvre; F D'Onofrio
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

3.  The Relationship Between β-Endorphin and Experimental Pain Sensitivity in Older Adults With Knee Osteoarthritis.

Authors:  Hyochol Ahn; Jun-Ho La; Jin M Chung; Hongyu Miao; Chengxue Zhong; Miyong Kim; Kyungeh An; Debra Lyon; Eunyoung Choi; Roger B Fillingim
Journal:  Biol Res Nurs       Date:  2019-05-30       Impact factor: 2.522

Review 4.  Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system.

Authors:  J B Van Bree; A G De Boer; M Danhof; D D Breimer
Journal:  Pharm World Sci       Date:  1993-02-19

5.  Distribution and concentration of immunoreactive parathyroid hormone in brain and pituitary of sheep.

Authors:  S Balabanova; O King; W M Teller; G Reinhardt
Journal:  Klin Wochenschr       Date:  1985-05-02

Review 6.  Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment.

Authors:  T Vogt; D Belluscio
Journal:  Aesthetic Plast Surg       Date:  1987       Impact factor: 2.326

7.  Relationship between cerebrospinal fluid beta-endorphin and plasma pituitary-gonadal hormone levels in women.

Authors:  C Nappi; F Petraglia; A Gambardella; G De Masellis; C Di Carlo; A R Genazzani; U Montemagno
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

8.  Beta-endorphin inhibits glucose production in the conscious dog.

Authors:  P M Radosevich; P E Williams; J R McRae; W W Lacy; D N Orth; N N Abumrad
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  beta-Endorphin: characteristics of binding sites in rabbit spinal cord.

Authors:  P Ferrara; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  [Physical exercise, endogenous opiates and pain regulation.].

Authors:  C Droste
Journal:  Schmerz       Date:  1991-09       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.